Legal Representation
Attorney
Jason M. Rhodes
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 23, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 30, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 30, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 30, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 16, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 15, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicated prescription vaginal hormone preparation for treatment of perimenopause, menopause, endometriosis, Polycystic Ovary Syndrome (PCOS), cysts, fibroids, and Premenstrual Dysphoric Disorder (PMDD); medicated, bio-identical estradiol and progesterone hormone replacement therapy preparation in the form of a vaginal cream.
First Use Anywhere:
Feb 1, 2024
First Use in Commerce:
Feb 1, 2024
Classification
International Classes
005